Press Releases

HarmonyCares Secures $200M to Expand Access to In-Home Primary Care

On July 8, 2024, home health care services company HarmonyCares announced that it has secured $200 million in fundraising from a variety of venture capital firms, including McKesson Ventures, General Catalyst, and K2 HealthVentures, among others. The new capital will allow HarmonyCares to expand its operations to “additional geographies and develop new technology to drive clinical outcomes and patient satisfaction at scale.”   CEO of HarmonyCares Matthew Chance expressed his excitement with the announcement, stating in a company press release that “This latest investment enables us...

ChatRWD™ Beta from Atropos Health Exceeds Big Tech LLMs on Physician Trust and Ability to Answer Questions Completely with High-Quality Evidence in New Study

On July 2, real-world data healthcare technology company Atropos Health announced in a press release the publication of its new research paper, “Answering Real-World Clinical Questions Using Large Language Model Based Systems.” The paper offers a detailed look into the company’s new AI-powered healthcare database platform, ChatRWD™, which uses real-world data to answer a variety of medical questions, making the platform “[superior] over other large language models (LLMs) when it comes to trust, quality, and accuracy (limited hallucinations).”  Dr. Saurabh Gombar, Chief Medical Officer and co-founder...

Atropos Health Raises $33M To Scale The Automation Of High-Quality, Personalized Real-World Evidence Leveraging Generative AI

On Thursday, May 23, real-world data healthcare technology company Atropos Health announced that it had secured a $33 million Series B financing round, in light of the recent adoption of the company’s GENEVA OS™ platform, which is now being used by a variety of medical practices and researchers across the healthcare industry. The Series B financing was led by WCAS portfolio company Valtruis, as well as other investors including Cencora Ventures, McKesson Ventures, Merck Global Health Innovation Fund, and more. With this funding, Atropos is...

SSM Health partners with Inbound Health to offer in-home advanced care to patients

Inbound Health and SSM Health have partnered up to offer post-hospital in-home health care services to patients. The SSM Health at Home program – Recovery Care at Home – will apply to certain patients who are ready to be discharged but who still need services traditionally offered in a skilled nursing facility. Phase one of the partnership kicked off at SSM Health St. Mary’s Hospital – Madison in April 2024. Dr. James Lehman, SSM Health Wisconsin Regional Clinical Program Medical Director commented on the health benefits...

CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List

On April 9, 2024, CancerIQ’s Founder and CEO Feyi Ayodele was named as one of Modern Healthcare’s Top Innovators of 2024. The list acknowledges innovators that are improving quality and access to care, as well as constantly striving to improve the clinical and financial results of their companies.  “I’m honored to receive this incredible recognition from Modern Healthcare,” said Feyi Ayodele in a press release on Tuesday. “I want to thank our team, investors, partners, and most importantly, our customers for believing in me and for...

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient demographics.  The research effort seeks to better understand the eligibility of patients for immune checkpoint inhibitor (ICI) therapy, a type of cancer treatment that boosts the body’s ability to battle cancerous cells. The project will begin by examining over 20,000 patients with “solid tumor malignancies,” and will then...

Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements

On Monday, January 22nd, life science solutions company Saama announced a variety of new additions to its AI-based platform. The new features include the release of generative AI chat, interactive review listings, and an increased prioritization of cross-functional collaboration, among others. These changes are the latest in a long line of the company’s efforts to improve the way that clinical trials and medical research is performed.  Chief Technology Officer and Chief Product Officer Lisa Moneymaker expressed her excitement with the announcement in Monday’s press release, saying,...

PM360 Announces the Selections for its 12th Annual Innovations Issue

On Thursday, December 14th, pharmaceutical marketing and trade magazine PM360 announced its list of innovators in the pharmaceutical, biotechnology, medical device, and biotechnology industries. These innovators were named for their achievements across a variety of areas, including Artificial Intelligence, Clinical Trials, Startups, and more, and included RxLightning as one of the innovators in the “Startups” category.  Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360, expressed her excitement with this year’s list of innovators in the company’s press release, stating, “We know the importance of innovation, which...

ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights’ Avatar Platform

Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple myeloma using data from Aster Avatar, including a longitudinal study of response to anti-BCMA CAR-T treatment. “ASH is a unique opportunity to demonstrate the impactful discoveries resulting from ORIEN and Aster Insights’ discovery solutions,” said Anand Shah, MD, CEO of Aster Insights. “This year, we...

New Study Shows Point-of-care Genetics May Improve Uptake, Reduce Racial Disparities

On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This study aims to identify which racial and ethnic groups are not receiving the necessary counseling and treatment and to explore ways in which this disparity can be improved.  Data from this study was collected from over 14,000 patients across 15 clinical sites and six states, identifying issues,...